Oral PTH1-34: Phase I started

Novartis began a placebo-controlled Phase I trial in 120 postmenopausal women to compare oral PTH1-34 vs. Forteo teriparatide from Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.). Novartis licensed...